Literature DB >> 10827323

Adrenal pheochromocytoma remains a frequently overlooked diagnosis.

C Y Lo1, K Y Lam, M S Wat, K S Lam.   

Abstract

BACKGROUND: Adrenal pheochromocytoma is potentially lethal if undetected and is associated with long-term morbidity.
METHODS: Records of patients (11 men, 18 women) with confirmed pheochromocytoma were studied with respect to clinicopathological features and outcome.
RESULTS: Pheochromocytoma was diagnosed in 4 of 8,486 (0.05%) autopsies and accounted for 3 of the 4 immediate causes of death. Operative mortality occurred in 1 patient with undiagnosed tumor. Hypertensive-related complications occurred in 6 patients before diagnosis. Malignancy was documented in 7 patients with distant metastases (n = 4) or locally invasive tumors (n = 3). During a median follow-up of 4 years, 23 patients are alive and free of disease (79%). Four of the 6 patients (67%) who died had distant metastases compared with 2 of 23 patients (9%) without distant metastases (P = 0.04). Persistent hypertension and diabetes requiring treatment were present in 8 (35%) and 4 (17%) of 23 patients respectively.
CONCLUSIONS: Fatal complications preceded diagnosis in a significant proportion of patients with pheochromocytoma. The presence of distant metastases was associated with poor survival.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10827323     DOI: 10.1016/s0002-9610(00)00296-8

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  22 in total

1.  Uncommon presentation, rare complication and previously undescribed oncologic association of pheochromocytoma; the great masquerader.

Authors:  David Lawrence; Kevan Salimian; Thorsten Leucker; Seth Martin
Journal:  BMJ Case Rep       Date:  2018-04-05

2.  An interesting case of paraganglioma.

Authors:  Azhar Ali Malik; Ali El Houni; Hassan Gulshad; Syed Elsiah; Suhail Al-Salam
Journal:  BMJ Case Rep       Date:  2009-05-25

Review 3.  Adrenal oncocytic phaeochromocytoma with putative adverse histologic features: a unique case report and review of the literature.

Authors:  Kais Kasem; Alfred K-Y Lam
Journal:  Endocr Pathol       Date:  2014-12       Impact factor: 3.943

Review 4.  Choice of biochemical test for diagnosis of pheochromocytoma: validation of plasma metanephrines.

Authors:  Graeme Eisenhofer; Jacques W M Lenders; Karel Pacak
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

5.  Clinical experiences of pheochromocytoma in Korea.

Authors:  Kwang Hyun Kim; Jae Seung Chung; Won Tae Kim; Cheol Kyu Oh; Yun Byung Chae; Ho Song Yu; Won Sik Ham; Young Deuk Choi
Journal:  Yonsei Med J       Date:  2011-01       Impact factor: 2.759

Review 6.  Screening for pheochromocytomas and paragangliomas.

Authors:  Graeme Eisenhofer
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

Review 7.  Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.

Authors:  Graeme Eisenhofer; Graham Rivers; Alejandro L Rosas; Zena Quezado; William M Manger; Karel Pacak
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 8.  Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism.

Authors:  William F Young
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514

Review 9.  Subclinical phaeochromocytoma.

Authors:  Massimo Mannelli; Jacques W M Lenders; Karel Pacak; Gabriele Parenti; Graeme Eisenhofer
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.690

10.  Secondary hypertension in adults.

Authors:  Troy Hai Kiat Puar; Yingjuan Mok; Roy Debajyoti; Joan Khoo; Choon How How; Alvin Kok Heong Ng
Journal:  Singapore Med J       Date:  2016-05       Impact factor: 1.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.